Drivers of cancer development: the inflammatory messenger oncostatin M...Charité - Universitätsmedizin Berlin
Adding Immune Checkpoint Inhibitor to Standard Chemotherapy Regimen Improves Outcomes in Stage 3 Colon Cancer, Study Fin...Dana-Farber Cancer Institute
A Dana-Farber study shows that an anti-inflammatory diet could extend overall survival after treatment for stage III col...Dana-Farber Cancer Institute
